Cite
APA Citation
Hapgood, G., Stone, J. M., Zannino, D., George, A., Marlton, P., Prince, H. M., Hui, C., Prosser, I., Lewis, I. D., Bradstock, K., Seymour, J. F., & , (2019). a phase II study of a modified hyper-CVAD frontline therapy for patients with adverse risk diffuse large B-cell and peripheral T-cell non-Hodgkin lymphoma. Leukemia & lymphoma, 60(4), 904–911. http://access.bl.uk/ark:/81055/vdc_100079933386.0x00005c